JHDD led the 2nd Annual Drug Discovery Symposium with UMB – JHDD/UMB Joint Drug Discovery Symposium, UMD
JHDD coauthors a report on a glutamine blocking drug that slows tumor growth [Science]
Partnership Awards $3 Million In Grants For Promising New Treatments In Alzheimer’s And Related Dementias
JHDD start-up Dracen Pharmaceuticals receives $40.5 million to develop Glutamine Antagonists
Our high throughput screening collaboration with Eisai and partnership with Institute of Organic Chemistry and Biochemistry represent innovative ways to create a great synergy of complimentary organizations working together to develop new therapeutics.